跳至主要内容
临床试验/JPRN-UMIN000039205
JPRN-UMIN000039205招募中未知

Genetic Alterations and clinical record in radically resected colorectal cancer revealed by Liquid biopsy And whole eXome analYsis - GALAXY trial

ational Research and Development Agency, National Cancer Center0 个研究点目标入组 6,300 人开始时间: 2020年1月20日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
6,300

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • (1) Two or more synchronous colorectal cancer (multiple cancer) * * In case of patients with stage II, III, IV or recurrent (M1) colorectal cancer according to the 8th edition of the UICC, patients with clinical stage Tis or T1a colorectal cancer judged to be cured by local treatment may be included in this study. * If patients with pT1 colorectal cancer after local resection (complete en bloc resection with negative margins), have other cancers up to clinical stage T1a that can be judged to be cured by local treatment, registration is possible only if it is confirmed that the cancer was radically resected by local treatment. (2) Active double cancer. (3) In case of enrolled in Cohort A or Cohort D, history of surgery, chemotherapy, immunotherapy, or radiotherapy within 6 months before enrollment. (4) Pregnant or breastfeeding women. (5) Serious complication. (6) Positive for HBs antigen or positive for HCV antibody*. *Patients who are positive for HCV antibody but negative for HCV-RNA is eligible. (7) HIV antibody positive (a patient may enroll even if HIV antibody has not been tested). (8) Active novel coronavirus infection (COVID-19) is present*. * Patients with positive SARS-CoV-2 PCR or suspected COVID-19 based on clinical symptoms; patients with confirmed negative SARS-CoV-2 PCR or other tests and no symptoms of COVID-19 may be include in this study. However, if the physician deem that the patients will affect the evaluation of this study, the patients are ineligible. (COVID-19 testing is not required). (9) The study doctor deemed that it is ineligible for this study.

研究者

相似试验